• $55.2M
    Market Cap
  • 15.09%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
-1.4M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
36,000
0.00%
36,000
N/A
N/A
N/A
Gross Profit
-1.4M
+3,680.92%
-36,000
0.00%
-36,000
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-9.8M
+3.48%
-9.4M
-39.04%
-15.5M
+72.24%
-9.0M
+6.95%
Depreciation and Amortization Expense
540,894
-17.18%
653,090
+12.04%
582,918
+47.94%
394,011
-44.37%
Total Operating Expenses
10.2M
+63.94%
6.2M
-14.67%
7.3M
-14.58%
8.5M
-30.67%
Operating Profit
-19.9M
+27.44%
-15.6M
-31.26%
-22.8M
+30.04%
-17.5M
-15.37%
Interest Income
369,267
+127.80%
162,099
N/A
N/A
N/A
N/A
N/A
Interest Expense
-1.4M
N/A
N/A
N/A
-790,000
+170.23%
-292,339
+775.08%
Interest Income and Expense and Net
-991,863
-711.89%
162,099
+120.52%
-790,000
+170.23%
-292,339
+775.08%
Total Nonoperating Income and Expense
-1.4M
-1,471.61%
99,236
+112.79%
-775,758
+344.52%
-174,514
+470.44%
Income before Taxes
-22.4M
+44.41%
-15.5M
-33.95%
-23.5M
+33.14%
-17.7M
-14.65%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
-23.5M
+33.14%
-17.7M
-14.65%
Net Income from Continuing Operations Applicable to Common
-22.4M
+44.41%
-15.5M
-33.95%
-23.5M
+33.14%
-17.7M
-14.65%
Basic EPS and Net Income
-4.44
-56.47%
-10.20
-60.77%
-26.00
+1,566.67%
-1.56
-44.09%
Diluted EPS and Net Income
-4.44
-56.47%
-10.20
-60.77%
-26.00
+1,566.67%
-1.56
-44.09%
Basic Weighted Average Shares
5.1M
+231.54%
1.5M
+68.44%
905,225
-92.00%
11.3M
+52.55%
Diluted Weighted Average Shares
5.1M
+231.54%
1.5M
+68.44%
905,225
-92.00%
11.3M
+52.55%
Balance Sheet
Cash and Cash Equivalents
11.0M
-10.30%
12.2M
+23,196.93%
52,416
-99.02%
5.4M
-67.52%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
11.0M
-10.30%
12.2M
+23,196.93%
52,416
-99.02%
5.4M
-67.53%
Total Current Assets
12.0M
-5.15%
12.7M
+2,088.20%
578,594
-92.65%
7.9M
-58.32%
Accumulated Depreciation
3.8M
+16.41%
3.3M
+24.71%
2.6M
+28.30%
2.1M
+23.65%
Property and Plant and Equipment and Net
1.7M
-18.00%
2.1M
-17.33%
2.5M
-12.35%
2.9M
-7.65%
Total Long-Term Assets
1.7M
-18.00%
2.1M
-17.33%
2.5M
-12.35%
2.9M
-7.65%
Total Assets
15.1M
+1.40%
14.9M
+325.74%
3.5M
-69.39%
11.4M
-50.17%
Income Taxes Payable
44,000
-78.00%
200,000
+65.88%
120,570
N/A
N/A
N/A
Total Short-Term Debt
6.3M
+149.14%
2.5M
-15.76%
3.0M
-40.00%
5.0M
N/A
Total Current Liabilities
10.3M
+107.41%
5.0M
-51.38%
10.2M
+45.82%
7.0M
+495.98%
Total Long-Term Debt
1.2M
-52.75%
2.4M
+16.04%
2.1M
N/A
N/A
N/A
Total Long-Term Liabilities
2.3M
-7.60%
2.4M
+1,703.77%
135,099
-73.52%
510,235
-38.41%
Total Liabilities
12.6M
+69.58%
7.4M
-28.49%
10.4M
+37.72%
7.5M
+268.29%
Retained Earnings
-132.4M
+22.02%
-108.5M
+16.73%
-92.9M
+33.91%
-69.4M
+34.17%
Total Stockholders Equity
N/A
N/A
N/A
N/A
-6.9M
-276.95%
3.9M
-81.38%
Total Shares Outstanding
7.3M
+113.10%
3.4M
+191.41%
1.2M
-89.68%
11.3M
0.00%
Cash Flow
Cash from Operating Activities
-17.2M
-6.54%
-18.5M
+22.73%
-15.0M
-5.34%
-15.9M
+52.24%
Capital Expenditures
162,138
-23.45%
211,800
-5.49%
224,096
+46.07%
153,420
-81.17%
Cash from Investing Activities
-162,138
-23.45%
-211,800
-5.49%
-224,096
+46.80%
-152,652
-81.26%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
16.1M
-47.60%
30.8M
+209.62%
10.0M
+103.20%
4.9M
-81.54%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
1,464.82%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
-315.98%
+206.50%
-103.09%
N/A
Return on Equity
N/A
N/A
N/A
N/A
1,575.61%
+1,201.98%
-142.98%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.16
-54.27%
2.55
+4,398.94%
0.06
-94.96%
1.12
N/A
Cash Ratio
1.06
-56.75%
2.46
+48,056.86%
0.005
-99.33%
0.76
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
-0.74
N/A
N/A
N/A
Debt-to-Assets Ratio
0.49
+47.98%
0.33
-77.14%
1.46
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow